Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD
Clin Transl Med
.
2022 Nov;12(11):e1122.
doi: 10.1002/ctm2.1122.
Author
Dariusz C Górecki
1
Affiliation
1
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
PMID:
36424805
PMCID:
PMC9691905
DOI:
10.1002/ctm2.1122
No abstract available
MeSH terms
Dystrophin* / genetics
Genetic Therapy
Muscle Development* / genetics
Substances
Dystrophin